Go Pro

PetVivo (PETV) Competitors

PetVivo logo
$0.84 +0.02 (+2.55%)
As of 07/8/2026 03:08 PM Eastern

PETV vs. RCEL, MBOT, FONR, LAKE, and VANI

Should you buy PetVivo stock or one of its competitors? MarketBeat compares PetVivo with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with PetVivo include Avita Medical (RCEL), Microbot Medical (MBOT), Fonar (FONR), Lakeland Industries (LAKE), and Vivani Medical (VANI). These companies are all part of the "medical equipment" industry.

How does PetVivo compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

Avita Medical has a beta of 1.86, meaning that its stock price is 86% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.23, meaning that its stock price is 23% more volatile than the broader market.

Avita Medical has a net margin of -62.67% compared to PetVivo's net margin of -902.82%. Avita Medical's return on equity of 0.00% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Avita Medical-62.67% N/A -78.92%
PetVivo -902.82%-4,813.07%-281.78%

Avita Medical currently has a consensus price target of $7.25, indicating a potential upside of 55.91%. Given Avita Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Avita Medical is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avita Medical
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 2.8% of Avita Medical shares are held by company insiders. Comparatively, 10.8% of PetVivo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Avita Medical and Avita Medical both had 1 articles in the media. Avita Medical's average media sentiment score of 0.81 beat PetVivo's score of 0.76 indicating that Avita Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avita Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PetVivo
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PetVivo has lower revenue, but higher earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avita Medical$71.61M2.00-$48.59M-$1.57N/A
PetVivo$1.05M30.19-$10.95M-$0.38N/A

Summary

Avita Medical beats PetVivo on 10 of the 15 factors compared between the two stocks.

How does PetVivo compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, media sentiment, dividends and earnings.

Microbot Medical has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.23, meaning that its stock price is 23% more volatile than the broader market.

Microbot Medical currently has a consensus target price of $6.63, indicating a potential upside of 254.28%. Given Microbot Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Microbot Medical is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microbot Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.60
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Microbot Medical and Microbot Medical both had 1 articles in the media. PetVivo's average media sentiment score of 0.76 beat Microbot Medical's score of 0.00 indicating that PetVivo is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Microbot Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PetVivo
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PetVivo has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbot MedicalN/AN/A-$13.14M-$0.26N/A
PetVivo$1.05M30.19-$10.95M-$0.38N/A

16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by insiders. Comparatively, 10.8% of PetVivo shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Microbot Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Microbot Medical's return on equity of -21.84% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbot MedicalN/A -21.84% -20.71%
PetVivo -902.82%-4,813.07%-281.78%

Summary

Microbot Medical beats PetVivo on 8 of the 15 factors compared between the two stocks.

How does PetVivo compare to Fonar?

Fonar (NASDAQ:FONR) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

In the previous week, PetVivo had 1 more articles in the media than Fonar. MarketBeat recorded 1 mentions for PetVivo and 0 mentions for Fonar. PetVivo's average media sentiment score of 0.76 beat Fonar's score of 0.00 indicating that PetVivo is being referred to more favorably in the news media.

Company Overall Sentiment
Fonar Neutral
PetVivo Positive

Fonar has higher revenue and earnings than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fonar$105.34M1.12$8.33M$1.0019.09
PetVivo$1.05M30.19-$10.95M-$0.38N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fonar
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

50.6% of Fonar shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 7.9% of Fonar shares are owned by insiders. Comparatively, 10.8% of PetVivo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Fonar has a net margin of 6.35% compared to PetVivo's net margin of -902.82%. Fonar's return on equity of 4.12% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Fonar6.35% 4.12% 3.07%
PetVivo -902.82%-4,813.07%-281.78%

Fonar has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market. Comparatively, PetVivo has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market.

Summary

Fonar beats PetVivo on 9 of the 14 factors compared between the two stocks.

How does PetVivo compare to Lakeland Industries?

Lakeland Industries (NASDAQ:LAKE) and PetVivo (NASDAQ:PETV) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

71.7% of Lakeland Industries shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 3.4% of Lakeland Industries shares are owned by company insiders. Comparatively, 10.8% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Lakeland Industries had 2 more articles in the media than PetVivo. MarketBeat recorded 3 mentions for Lakeland Industries and 1 mentions for PetVivo. PetVivo's average media sentiment score of 0.76 beat Lakeland Industries' score of 0.33 indicating that PetVivo is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Lakeland Industries
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PetVivo
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Lakeland Industries has a net margin of -10.87% compared to PetVivo's net margin of -902.82%. Lakeland Industries' return on equity of -6.64% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Lakeland Industries-10.87% -6.64% -4.13%
PetVivo -902.82%-4,813.07%-281.78%

Lakeland Industries currently has a consensus target price of $16.00, suggesting a potential upside of 42.22%. Given Lakeland Industries' stronger consensus rating and higher possible upside, research analysts clearly believe Lakeland Industries is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lakeland Industries
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Lakeland Industries has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market. Comparatively, PetVivo has a beta of 1.23, suggesting that its share price is 23% more volatile than the broader market.

PetVivo has lower revenue, but higher earnings than Lakeland Industries. Lakeland Industries is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lakeland Industries$192.65M0.58-$25.31M-$2.13N/A
PetVivo$1.05M30.19-$10.95M-$0.38N/A

Summary

Lakeland Industries beats PetVivo on 10 of the 16 factors compared between the two stocks.

How does PetVivo compare to Vivani Medical?

PetVivo (NASDAQ:PETV) and Vivani Medical (NASDAQ:VANI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

In the previous week, Vivani Medical had 7 more articles in the media than PetVivo. MarketBeat recorded 8 mentions for Vivani Medical and 1 mentions for PetVivo. PetVivo's average media sentiment score of 0.76 beat Vivani Medical's score of -0.04 indicating that PetVivo is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PetVivo
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Vivani Medical
0 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

PetVivo has a beta of 1.23, indicating that its stock price is 23% more volatile than the broader market. Comparatively, Vivani Medical has a beta of 2.33, indicating that its stock price is 133% more volatile than the broader market.

Vivani Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Vivani Medical's return on equity of -264.04% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
PetVivo-902.82% -4,813.07% -281.78%
Vivani Medical N/A -264.04%-79.85%

Vivani Medical has a consensus target price of $3.75, indicating a potential upside of 134.38%. Given Vivani Medical's stronger consensus rating and higher possible upside, analysts clearly believe Vivani Medical is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Vivani Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

PetVivo has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetVivo$1.05M30.19-$10.95M-$0.38N/A
Vivani MedicalN/AN/A-$26.61M-$0.40N/A

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 6.8% of Vivani Medical shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 53.3% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Vivani Medical beats PetVivo on 9 of the 15 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PETV vs. The Competition

MetricPetVivoSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$31.58M$44.11M$7.00B$12.46B
Dividend YieldN/A1.08%2.67%7.39%
P/E Ratio-1.8719.8427.1424.24
Price / Sales30.1929.25534.0596.53
Price / CashN/A18.8649.2456.96
Price / Book-28.008.4210.836.38
Net Income-$10.95M-$20.01M$3.56B$331.19M
7 Day Performance1.06%-3.92%-0.02%-1.32%
1 Month Performance5.04%2.22%5.28%1.27%
1 Year Performance12.00%-7.32%30.31%20.73%

PetVivo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PETV
PetVivo
N/A$0.84
+2.6%
N/A+12.0%$31.58M$1.05MN/A20
RCEL
Avita Medical
3.5735 of 5 stars
$3.97
+1.3%
$7.25
+82.6%
-17.1%$120.64M$71.61MN/A130
MBOT
Microbot Medical
1.9675 of 5 stars
$1.78
+0.3%
$6.63
+273.2%
-24.6%$118.88MN/AN/A20
FONR
Fonar
2.1739 of 5 stars
$19.09
flat
N/AN/A$117.84M$105.34M19.09480
LAKE
Lakeland Industries
3.3869 of 5 stars
$10.80
-0.2%
$16.00
+48.1%
-22.7%$106.78M$192.65MN/A2,600

Related Companies and Tools


This page (NASDAQ:PETV) was last updated on 7/9/2026 by MarketBeat.com Staff.
From Our Partners